Role of genetic factors in development of gastric carcinoma;De rol van genetische factoren bij her ontstaan van maagcarcinoom

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 7, 1999, Pages 342-346

  Taal, B G ^a   Van Loon, H J ^a   Kahn, N ^b   De Jong, D ^a   Vasen, H F A ^b   Van 'T Veer, L J ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b Stichting Opsporing Erfelijke Tumoren   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN P53; RAS PROTEIN;

AGING; ATROPHIC GASTRITIS; CANCER LOCALIZATION; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; DNA REPAIR; FAMILIAL CANCER; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HELICOBACTER PYLORI; HUMAN; ONSET AGE; PEDIGREE ANALYSIS; REVIEW; STOMACH CARCINOMA;

ADULT; AGED; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA PROBES; DNA REPAIR; FEMALE; GENES, APC; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REGISTRIES; STOMACH NEOPLASMS;

EID: 0033550758     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Kok TC. Het maagcarcinoom: biologisch gedrag en stadium. Ned Tijdschr Geneeskd 1989;133:1819-22.
2. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
4. Vasen HFA, Taal BG, Griffioen G, Nagengast FM, Cats A, Menko FH, et al. Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols. Gut 1994;35:1262-6.
5. Zanghieri G, Di Gregorio C, Sacchetti C, Fante R, Sassatelli R, Cannizzo G, et al. Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 1990;66:2047-51.
6. La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer 1992;70:50-5.
7. Mecklin JP, Nordling S, Saario I. Carcinoma of the stomach and its heredity in young patients. Scand J Gastroenterol 1988;23:307-11.
8. Sokoloff B. Predisposition to cancer in the Bonaparte family. Am J Surg 1938;40:673-8.
9. Peltomäki P, Lothe RA, Aaltonen LA, Pylkkänen L, Nyström-Lahti M, Scruca R, et al. Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 1993;53:5853-5.
10. Liu B, Farrington SM, Petersen GM, Hamilton SR, Parsons R, Papadopoulos N, et al. Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med 1995;1:348-52.
11. Han HJ, Yanagisawa A, Kato Y, Park JG, Nakamura Y. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 1993;53:5087-9.
12. Chung YJ, Song JM, Lee JY, Jung YT, Seo EJ, Choi SW, et al. Microsatellite instability-associated mutations associate preferentially with the intestinal type of primary gastric carcinomas in a high-risk population. Cancer Res 1996;56:4662-5.
13. Rhyu MG, Park WS, Meltzer SJ. Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene 1994;9:29-32.
14. Seruca R, Santus NR, David L, Constancia M, Barroca H, Carneiro F, et al. Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile. Int J Cancer 1995; 64:32-6.
15. Semba S, Yokozaki H, Yamamoto S, Yasui W, Tahara E. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Cancer 1996;77(8 Suppl):1620-7.
16. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL, Russell SEH. Widespread microsatellite instability occurs infrequently in adenocarcinoma of the gastric cardia. Oncogene 1996; 12:1653-62.
17. Hayden JD, Cawkwell L, Sue-Ling H, Johnston D, Dixon MF, Ouirke P, et al. Assessment of microsatellite alterations in young patients with gastric adenocarcinoma. Cancer 1997;79:684-7.
18. Ottini L, Palli D, Falchetti M, D'Amico C, Amorosi A, Saieva C, et al. Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res 1997;57:4523-9.
19. Hayden JD, Martin IG, Cawkwell L, Quirke P. The role of microsatellite instability in gastric carcinoma. Gut 1998;42:300-3.
20. Sasaki A, Nagushima M, Shiseki M, Katai H, Maruyama K, Iwanaga R, et al. Microsatellite instability in gastric cancer prone families. Cancer Lett 1996;99:169-75.
21. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402-5.
22. Craanen ME, Blok P, Dekker W, Offerhaus GJA, Tytgat GNJ. Chronology of p53 protcir accumulation in gastric carcinogenesis. Gut 1995;36:848-52.
23. Fukunaga M, Monden T, Nakanishi H, Ohue M, Fukuda K, Tomita N, et al. Immunohistochemical study of p53 in gastric carcinoma. Am J Clin Pathol 1994;101:177-80.
24. Tamura G, Kihana T, Nomura K, Terada M, Sugimura T, Hirohashi S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res 1991;51:3056-8.
25. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 1993;54:759-64.
26. Tateishi M, Toda T, Minamisono Y, Nagasaki S. Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma. J Surg Oncol 1992;49:209-12.
27. Falck VG, Gullick WJ. C-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study. J Pathol 1989; 159:107-11.
28. Blok P, Craanen ME, Dekker W, Offerhaus GJA, Tytgat GNJ. No evidence for C-erbB-2 overexpression in gastric carcinogenesis. Histopathology 1998;32:335-9.
29. Houldsworth J, Cordon-Cardo C, Ladanyi M, Kelsen DP, Chaganti RSH. Gene amplification in gastric and esophageal adenocarcinomas. Cancer Res 1990;50:6417-22.
30. Nakatani H, Sakamoto H, Yoshida T, Yokota J, Tahara E, Sugimura T, et al. Isolation of an amplified DNA sequence in stomach cancer. Jpn J Cancer Res 1990;81:707-10.
31. Kim YJ, Ghu HD, Kim DY, Kim HJ, Kim SK, Park CS. Expression of cellular oncogenes in human gastric carcinoma: c-myc, c-erbB-2, and c-Ha-ras. J Surg Oncol 1993;54:167-70.
32. Lin SY, Chen PH, Wang CK, Liu JD, Siauw CP, Chen YJ, et al. Mutation analysis of K-ras oncogenes in gastroenterologic cancers by the amplified created restriction sites method. Am J Clin Pathol 1993;100:686-9.
33. Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, et al. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res 1991;51:2926-31.
34. McKie AB, Filipe MI, Lemoine NR. Abnormalities affecting the APC and MCC tumour suppressor gene loci on chromosome 5q occur frequently in gastric cancer, but not in pancreatic cancer. Int J Cancer 1993;55:598-603.
35. Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Kato Y, et al. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res 1992;52:3231-3.
36. Nakatsuru S, Yanagisawa A, Ichii S, Tahara E, Kato Y, Nakamura Y, et al. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet 1992;1:559-63.
37. Taal BG, Loon HJ van, Boot H, Vasen H. The prevalence of hereditary gastric cancer (HGC) [abstract]. Eur J Gastroenterol Hepatol 1996;8:A35.